Listed

Inhibrx Biosciences, Inc.

INBXNasdaqCIK 2007919HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q2 FY2026
Operating income−$32.1m, Q2 FY2026
Net income−$36.6m, Q2 FY2026
Inhibrx Biosciences, Inc., income statement, quarterly
Line itemUnitperiod not labelled2023-09-30period not labelled2023-12-31period not labelled2024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m0.1Revenue, period not labelled, three months to 2023-09-30$119.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-14, accession 0002007919-24-000058.Report this figure1.6Revenue, period not labelled, three months to 2023-12-31$1.6m. XBRL concept us-gaap:Revenues. 10-K filed 2025-03-17, accession 0002007919-25-000019. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, period not labelled, three months to 2024-03-31$0. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-14, accession 0002007919-25-000056.Report this figure0.1Revenue, Q2 FY2024, three months to 2024-06-30$100.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-13, accession 0002007919-25-000081.Report this figure0.0Revenue, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-14, accession 0002007919-25-000093.Report this figure0.1Revenue, Q4 FY2024, three months to 2024-12-31$100.0k. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-19, accession 0002007919-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-14, accession 0002007919-25-000056.Report this figure1.3Revenue, Q2 FY2025, three months to 2025-06-30$1.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0002007919-26-000042.Report this figure0.0Revenue, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-14, accession 0002007919-25-000093.Report this figure0.0Revenue, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-19, accession 0002007919-26-000006. Derived: 12-month figure less the 9-month figure.Report this figurenot reported0.0Revenue, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0002007919-26-000042.Report this figure
Research and development$m38.1Research and development, period not labelled, three months to 2023-09-30$38.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-14, accession 0002007919-24-000058.Report this figure82.1Research and development, period not labelled, three months to 2023-12-31$82.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-17, accession 0002007919-25-000019. Derived: 12-month figure less the 9-month figure.Report this figure63.9Research and development, period not labelled, three months to 2024-03-31$63.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-14, accession 0002007919-25-000056.Report this figure67.6Research and development, Q2 FY2024, three months to 2024-06-30$67.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-13, accession 0002007919-25-000081.Report this figure38.9Research and development, Q3 FY2024, three months to 2024-09-30$38.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-14, accession 0002007919-25-000093.Report this figure33.4Research and development, Q4 FY2024, three months to 2024-12-31$33.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-19, accession 0002007919-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure36.9Research and development, Q1 FY2025, three months to 2025-03-31$36.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0002007919-26-000027.Report this figure22.3Research and development, Q2 FY2025, three months to 2025-06-30$22.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0002007919-26-000042.Report this figure28.5Research and development, Q3 FY2025, three months to 2025-09-30$28.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-14, accession 0002007919-25-000093.Report this figure25.3Research and development, Q4 FY2025, three months to 2025-12-31$25.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-19, accession 0002007919-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure25.2Research and development, Q1 FY2026, three months to 2026-03-31$25.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0002007919-26-000027.Report this figure23.9Research and development, Q2 FY2026, three months to 2026-06-30$23.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0002007919-26-000042.Report this figure
Operating income$m(45.8)Operating income, period not labelled, three months to 2023-09-30−$45.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-14, accession 0002007919-24-000058.Report this figure(88.3)Operating income, period not labelled, three months to 2023-12-31−$88.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-17, accession 0002007919-25-000019. Derived: 12-month figure less the 9-month figure.Report this figure(73.8)Operating income, period not labelled, three months to 2024-03-31−$73.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-14, accession 0002007919-25-000056.Report this figure(161)Operating income, Q2 FY2024, three months to 2024-06-30−$160.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-13, accession 0002007919-25-000081.Report this figure(46.8)Operating income, Q3 FY2024, three months to 2024-09-30−$46.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0002007919-25-000093.Report this figure(49.9)Operating income, Q4 FY2024, three months to 2024-12-31−$49.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-19, accession 0002007919-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure(42.9)Operating income, Q1 FY2025, three months to 2025-03-31−$42.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0002007919-26-000027.Report this figure(27.4)Operating income, Q2 FY2025, three months to 2025-06-30−$27.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0002007919-26-000042.Report this figure(33.8)Operating income, Q3 FY2025, three months to 2025-09-30−$33.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0002007919-25-000093.Report this figure(30.9)Operating income, Q4 FY2025, three months to 2025-12-31−$30.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-19, accession 0002007919-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure(30.9)Operating income, Q1 FY2026, three months to 2026-03-31−$30.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0002007919-26-000027.Report this figure(32.1)Operating income, Q2 FY2026, three months to 2026-06-30−$32.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0002007919-26-000042.Report this figure
Interest expense$m8.1Interest expense, period not labelled, three months to 2023-09-30$8.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2024-11-14, accession 0002007919-24-000058.Report this figure8.2Interest expense, period not labelled, three months to 2023-12-31$8.2m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2025-03-17, accession 0002007919-25-000019. Derived: 12-month figure less the 9-month figure.Report this figure8.1Interest expense, period not labelled, three months to 2024-03-31$8.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-05-14, accession 0002007919-25-000056.Report this figure5.4Interest expense, Q2 FY2024, three months to 2024-06-30$5.4m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-13, accession 0002007919-25-000081.Report this figure0.0Interest expense, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-14, accession 0002007919-25-000093.Report this figure0.0Interest expense, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-19, accession 0002007919-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure2.7Interest expense, Q1 FY2025, three months to 2025-03-31$2.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-14, accession 0002007919-26-000027.Report this figure3.1Interest expense, Q2 FY2025, three months to 2025-06-30$3.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-13, accession 0002007919-26-000042.Report this figure3.2Interest expense, Q3 FY2025, three months to 2025-09-30$3.2m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-14, accession 0002007919-25-000093.Report this figure3.2Interest expense, Q4 FY2025, three months to 2025-12-31$3.2m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-19, accession 0002007919-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure3.5Interest expense, Q1 FY2026, three months to 2026-03-31$3.5m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-14, accession 0002007919-26-000027.Report this figure5.7Interest expense, Q2 FY2026, three months to 2026-06-30$5.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-13, accession 0002007919-26-000042.Report this figure
Income tax$m0.0Income tax, period not labelled, three months to 2023-09-30$2.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-14, accession 0002007919-24-000058.Report this figure(0.0)Income tax, period not labelled, three months to 2023-12-31−$4.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-17, accession 0002007919-25-000019. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, period not labelled, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-14, accession 0002007919-25-000056.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$2.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-13, accession 0002007919-25-000081.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-14, accession 0002007919-25-000093.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-19, accession 0002007919-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-14, accession 0002007919-26-000027.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$2.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-13, accession 0002007919-26-000042.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-14, accession 0002007919-25-000093.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-19, accession 0002007919-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-14, accession 0002007919-26-000027.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$3.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-13, accession 0002007919-26-000042.Report this figure
Net income$m(51.8)Net income, period not labelled, three months to 2023-09-30−$51.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-14, accession 0002007919-24-000058.Report this figure(93.6)Net income, period not labelled, three months to 2023-12-31−$93.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-17, accession 0002007919-25-000019. Derived: 12-month figure less the 9-month figure.Report this figure(78.7)Net income, period not labelled, three months to 2024-03-31−$78.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0002007919-25-000093.Report this figure1,858Net income, Q2 FY2024, three months to 2024-06-30$1.86bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0002007919-25-000093.Report this figure(43.9)Net income, Q3 FY2024, three months to 2024-09-30−$43.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0002007919-25-000093.Report this figure(47.9)Net income, Q4 FY2024, three months to 2024-12-31−$47.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-19, accession 0002007919-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure(43.3)Net income, Q1 FY2025, three months to 2025-03-31−$43.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0002007919-26-000042.Report this figure(28.7)Net income, Q2 FY2025, three months to 2025-06-30−$28.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0002007919-26-000042.Report this figure(35.3)Net income, Q3 FY2025, three months to 2025-09-30−$35.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0002007919-25-000093.Report this figure(32.8)Net income, Q4 FY2025, three months to 2025-12-31−$32.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-19, accession 0002007919-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure(33.4)Net income, Q1 FY2026, three months to 2026-03-31−$33.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0002007919-26-000042.Report this figure(36.7)Net income, Q2 FY2026, three months to 2026-06-30−$36.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0002007919-26-000042.Report this figure
Diluted EPS$ per share(4.39)Diluted EPS, period not labelled, three months to 2023-09-30−$4.39 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-14, accession 0002007919-24-000058.Report this figurenot reported(5.77)Diluted EPS, period not labelled, three months to 2024-03-31−$5.77 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-14, accession 0002007919-25-000056.Report this figure125.48Diluted EPS, Q2 FY2024, three months to 2024-06-30$125.48 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-13, accession 0002007919-25-000081.Report this figure(2.84)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$2.84 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0002007919-25-000093.Report this figurenot reported(2.80)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$2.80 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0002007919-26-000027.Report this figure(1.85)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$1.85 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0002007919-26-000042.Report this figure(2.28)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$2.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0002007919-25-000093.Report this figurenot reported(2.15)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$2.15 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0002007919-26-000027.Report this figure(2.34)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$2.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0002007919-26-000042.Report this figure
Basic EPS$ per share(4.39)Basic EPS, period not labelled, three months to 2023-09-30−$4.39 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-14, accession 0002007919-24-000058.Report this figurenot reported(5.77)Basic EPS, period not labelled, three months to 2024-03-31−$5.77 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-14, accession 0002007919-25-000056.Report this figure127.10Basic EPS, Q2 FY2024, three months to 2024-06-30$127.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-13, accession 0002007919-25-000081.Report this figure(2.84)Basic EPS, Q3 FY2024, three months to 2024-09-30−$2.84 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0002007919-25-000093.Report this figurenot reported(2.80)Basic EPS, Q1 FY2025, three months to 2025-03-31−$2.80 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0002007919-26-000027.Report this figure(1.85)Basic EPS, Q2 FY2025, three months to 2025-06-30−$1.85 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0002007919-26-000042.Report this figure(2.28)Basic EPS, Q3 FY2025, three months to 2025-09-30−$2.28 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0002007919-25-000093.Report this figurenot reported(2.15)Basic EPS, Q1 FY2026, three months to 2026-03-31−$2.15 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0002007919-26-000027.Report this figure(2.34)Basic EPS, Q2 FY2026, three months to 2026-06-30−$2.34 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0002007919-26-000042.Report this figure

Balance sheet

Cash and equivalents$133.3m, Q2 FY2026
Long-term debt$176.3m, Q2 FY2026
Shareholders' equity−$53.0m, Q2 FY2026
Inhibrx Biosciences, Inc., balance sheet, quarterly
Line itemUnitperiod not labelled2023-09-30period not labelled2023-12-31period not labelled2024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$mnot reported278Cash and equivalents, period not labelled, at 2023-12-31$277.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-17, accession 0002007919-25-000019.Report this figurenot reported227Cash and equivalents, Q2 FY2024, at 2024-06-30$226.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-13, accession 0002007919-24-000029.Report this figure196Cash and equivalents, Q3 FY2024, at 2024-09-30$196.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-14, accession 0002007919-24-000058.Report this figure153Cash and equivalents, FY2024, at 2024-12-31$152.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-19, accession 0002007919-26-000006.Report this figure217Cash and equivalents, Q1 FY2025, at 2025-03-31$216.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-14, accession 0002007919-25-000056.Report this figure187Cash and equivalents, Q2 FY2025, at 2025-06-30$186.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-13, accession 0002007919-25-000081.Report this figure153Cash and equivalents, Q3 FY2025, at 2025-09-30$153.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-14, accession 0002007919-25-000093.Report this figure124Cash and equivalents, FY2025, at 2025-12-31$124.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0002007919-26-000042.Report this figure162Cash and equivalents, Q1 FY2026, at 2026-03-31$161.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-14, accession 0002007919-26-000027.Report this figure133Cash and equivalents, Q2 FY2026, at 2026-06-30$133.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0002007919-26-000042.Report this figure
Current assets$mnot reported295Current assets, period not labelled, at 2023-12-31$295.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-17, accession 0002007919-25-000019.Report this figurenot reported242Current assets, Q2 FY2024, at 2024-06-30$242.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-13, accession 0002007919-24-000029.Report this figure207Current assets, Q3 FY2024, at 2024-09-30$207.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0002007919-24-000058.Report this figure160Current assets, FY2024, at 2024-12-31$160.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-19, accession 0002007919-26-000006.Report this figure223Current assets, Q1 FY2025, at 2025-03-31$223.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-14, accession 0002007919-25-000056.Report this figure194Current assets, Q2 FY2025, at 2025-06-30$194.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-13, accession 0002007919-25-000081.Report this figure161Current assets, Q3 FY2025, at 2025-09-30$161.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-14, accession 0002007919-25-000093.Report this figure133Current assets, FY2025, at 2025-12-31$132.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0002007919-26-000042.Report this figure171Current assets, Q1 FY2026, at 2026-03-31$171.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-14, accession 0002007919-26-000027.Report this figure142Current assets, Q2 FY2026, at 2026-06-30$142.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0002007919-26-000042.Report this figure
Total assets$mnot reported308Total assets, period not labelled, at 2023-12-31$307.9m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-17, accession 0002007919-25-000019.Report this figurenot reported258Total assets, Q2 FY2024, at 2024-06-30$258.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-13, accession 0002007919-24-000029.Report this figure223Total assets, Q3 FY2024, at 2024-09-30$222.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-14, accession 0002007919-24-000058.Report this figure181Total assets, FY2024, at 2024-12-31$180.8m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-19, accession 0002007919-26-000006.Report this figure243Total assets, Q1 FY2025, at 2025-03-31$242.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-14, accession 0002007919-25-000056.Report this figure212Total assets, Q2 FY2025, at 2025-06-30$212.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-13, accession 0002007919-25-000081.Report this figure177Total assets, Q3 FY2025, at 2025-09-30$177.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-14, accession 0002007919-25-000093.Report this figure146Total assets, FY2025, at 2025-12-31$146.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0002007919-26-000042.Report this figure184Total assets, Q1 FY2026, at 2026-03-31$184.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-14, accession 0002007919-26-000027.Report this figure154Total assets, Q2 FY2026, at 2026-06-30$154.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0002007919-26-000042.Report this figure
Current liabilities$mnot reported56.3Current liabilities, period not labelled, at 2023-12-31$56.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-17, accession 0002007919-25-000019.Report this figurenot reported39.1Current liabilities, Q2 FY2024, at 2024-06-30$39.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-13, accession 0002007919-24-000029.Report this figure44.1Current liabilities, Q3 FY2024, at 2024-09-30$44.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-14, accession 0002007919-24-000058.Report this figure40.7Current liabilities, FY2024, at 2024-12-31$40.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-19, accession 0002007919-26-000006.Report this figure43.6Current liabilities, Q1 FY2025, at 2025-03-31$43.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-14, accession 0002007919-25-000056.Report this figure38.9Current liabilities, Q2 FY2025, at 2025-06-30$38.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-13, accession 0002007919-25-000081.Report this figure36.0Current liabilities, Q3 FY2025, at 2025-09-30$36.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-14, accession 0002007919-25-000093.Report this figure33.8Current liabilities, FY2025, at 2025-12-31$33.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0002007919-26-000042.Report this figure26.5Current liabilities, Q1 FY2026, at 2026-03-31$26.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-14, accession 0002007919-26-000027.Report this figure28.1Current liabilities, Q2 FY2026, at 2026-06-30$28.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0002007919-26-000042.Report this figure
Total liabilities$mnot reported264Total liabilities, period not labelled, at 2023-12-31$264.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-17, accession 0002007919-25-000019.Report this figurenot reported39.1Total liabilities, Q2 FY2024, at 2024-06-30$39.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-13, accession 0002007919-24-000029.Report this figure44.1Total liabilities, Q3 FY2024, at 2024-09-30$44.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-14, accession 0002007919-24-000058.Report this figure47.2Total liabilities, FY2024, at 2024-12-31$47.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-19, accession 0002007919-26-000006.Report this figure148Total liabilities, Q1 FY2025, at 2025-03-31$148.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-14, accession 0002007919-25-000056.Report this figure144Total liabilities, Q2 FY2025, at 2025-06-30$143.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-13, accession 0002007919-25-000081.Report this figure141Total liabilities, Q3 FY2025, at 2025-09-30$140.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-14, accession 0002007919-25-000093.Report this figure138Total liabilities, FY2025, at 2025-12-31$138.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0002007919-26-000042.Report this figure205Total liabilities, Q1 FY2026, at 2026-03-31$205.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-14, accession 0002007919-26-000027.Report this figure207Total liabilities, Q2 FY2026, at 2026-06-30$207.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0002007919-26-000042.Report this figure
Long-term debt$mnot reported207Long-term debt, period not labelled, at 2023-12-31$207.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-03-17, accession 0002007919-25-000019.Report this figurenot reported0.0Long-term debt, Q2 FY2024, at 2024-06-30$0. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-13, accession 0002007919-24-000029.Report this figure0.0Long-term debt, Q3 FY2024, at 2024-09-30$0. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-14, accession 0002007919-24-000058.Report this figure0.0Long-term debt, FY2024, at 2024-12-31$0. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-03-19, accession 0002007919-26-000006.Report this figure98.7Long-term debt, Q1 FY2025, at 2025-03-31$98.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-14, accession 0002007919-25-000056.Report this figure99.3Long-term debt, Q2 FY2025, at 2025-06-30$99.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-13, accession 0002007919-25-000081.Report this figure99.9Long-term debt, Q3 FY2025, at 2025-09-30$99.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-14, accession 0002007919-25-000093.Report this figure101Long-term debt, FY2025, at 2025-12-31$100.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-13, accession 0002007919-26-000042.Report this figure175Long-term debt, Q1 FY2026, at 2026-03-31$175.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-14, accession 0002007919-26-000027.Report this figure176Long-term debt, Q2 FY2026, at 2026-06-30$176.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-13, accession 0002007919-26-000042.Report this figure
Shareholders' equity$m130Shareholders' equity, period not labelled, at 2023-09-30$129.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-14, accession 0002007919-24-000058.Report this figure43.5Shareholders' equity, period not labelled, at 2023-12-31$43.5m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-19, accession 0002007919-26-000006.Report this figure11.6Shareholders' equity, period not labelled, at 2024-03-31$11.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0002007919-25-000093.Report this figure219Shareholders' equity, Q2 FY2024, at 2024-06-30$219.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0002007919-25-000093.Report this figure178Shareholders' equity, Q3 FY2024, at 2024-09-30$178.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0002007919-25-000093.Report this figure134Shareholders' equity, FY2024, at 2024-12-31$133.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0002007919-26-000042.Report this figure94.4Shareholders' equity, Q1 FY2025, at 2025-03-31$94.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0002007919-26-000042.Report this figure68.6Shareholders' equity, Q2 FY2025, at 2025-06-30$68.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0002007919-26-000042.Report this figure36.8Shareholders' equity, Q3 FY2025, at 2025-09-30$36.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0002007919-25-000093.Report this figure8.0Shareholders' equity, FY2025, at 2025-12-31$8.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0002007919-26-000042.Report this figure(21.0)Shareholders' equity, Q1 FY2026, at 2026-03-31−$21.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0002007919-26-000042.Report this figure(53.0)Shareholders' equity, Q2 FY2026, at 2026-06-30−$53.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0002007919-26-000042.Report this figure

Cash flow

Operating cash flow−$29.9m, Q2 FY2026
Capital expenditure$0, Q2 FY2026
Inhibrx Biosciences, Inc., cash flow, quarterly
Line itemUnitperiod not labelled2023-09-30period not labelled2023-12-31period not labelled2024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(54.2)Operating cash flow, period not labelled, three months to 2023-09-30−$54.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0002007919-24-000058. Derived: 9-month figure less the 6-month figure.Report this figure(56.8)Operating cash flow, period not labelled, three months to 2023-12-31−$56.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-17, accession 0002007919-25-000019. Derived: 12-month figure less the 9-month figure.Report this figure(63.1)Operating cash flow, period not labelled, three months to 2024-03-31−$63.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-14, accession 0002007919-25-000056.Report this figure(57.4)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$57.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-13, accession 0002007919-25-000081. Derived: 6-month figure less the 3-month figure.Report this figure(30.3)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$30.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0002007919-25-000093. Derived: 9-month figure less the 6-month figure.Report this figure(43.7)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$43.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-19, accession 0002007919-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure(35.9)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$35.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0002007919-26-000027.Report this figure(30.0)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$30.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0002007919-26-000042. Derived: 6-month figure less the 3-month figure.Report this figure(33.8)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$33.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0002007919-25-000093. Derived: 9-month figure less the 6-month figure.Report this figure(30.1)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$30.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-19, accession 0002007919-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure(38.0)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$38.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0002007919-26-000027.Report this figure(29.9)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$29.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0002007919-26-000042. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.8Capital expenditure, period not labelled, three months to 2023-09-30$811.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-14, accession 0002007919-24-000058. Derived: 9-month figure less the 6-month figure.Report this figure3.4Capital expenditure, period not labelled, three months to 2023-12-31$3.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-17, accession 0002007919-25-000019. Derived: 12-month figure less the 9-month figure.Report this figure1.1Capital expenditure, period not labelled, three months to 2024-03-31$1.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-14, accession 0002007919-25-000056.Report this figure1.2Capital expenditure, Q2 FY2024, three months to 2024-06-30$1.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-13, accession 0002007919-25-000081. Derived: 6-month figure less the 3-month figure.Report this figure0.2Capital expenditure, Q3 FY2024, three months to 2024-09-30$247.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-14, accession 0002007919-25-000093. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$16.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-19, accession 0002007919-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$21.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0002007919-26-000027.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0002007919-26-000042. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$10.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-14, accession 0002007919-25-000093. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-19, accession 0002007919-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0002007919-26-000027.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0002007919-26-000042. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)15.67m, Q2 FY2026
Inhibrx Biosciences, Inc., shares, quarterly
Line itemUnitperiod not labelled2023-06-30period not labelled2023-09-30period not labelled2024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares10.9Diluted shares (weighted), period not labelled, three months to 2023-06-3010,911,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-13, accession 0002007919-24-000029.Report this figure11.8Diluted shares (weighted), period not labelled, three months to 2023-09-3011,788,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-14, accession 0002007919-24-000058.Report this figure13.6Diluted shares (weighted), period not labelled, three months to 2024-03-3113,639,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-14, accession 0002007919-25-000056.Report this figure14.8Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3014,807,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-13, accession 0002007919-25-000081.Report this figure15.5Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3015,468,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-14, accession 0002007919-25-000093.Report this figure15.5Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3115,468,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0002007919-26-000027.Report this figure15.5Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3015,468,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0002007919-26-000042.Report this figure15.5Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3015,478,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-14, accession 0002007919-25-000093.Report this figure15.6Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3115,585,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0002007919-26-000027.Report this figure15.7Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3015,669,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0002007919-26-000042.Report this figure

Shares outstanding: 14.72mShares outstanding, period not labelled, at 2026-08-0714,717,660 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-13, accession 0002007919-26-000042.Report this figure at Aug 7, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. Listed shows no prices and gives no investment advice.